Skip to main content
. 2020 Dec 3;9(12):2589. doi: 10.3390/cells9122589

Figure 2.

Figure 2

Soluble CD6 decoy receptor-based therapeutic strategies in infection, immunomodulation, autoimmunity, and cancer. Reported CD6 ligands and their therapeutic targets. ALCAM, Activated Leukocyte Cell Adhesion Molecule; CD, cluster of differentiation; CDCP1, CUB domain-containing protein 1; CIA, Collagen Induced Arthritis; CLL, chronic lymphocytic leukemia; CMV, cytomegalovirus; HIV, human immunodeficiency virus; LTA, Lipoteichoic acid; LPS, lipopolysaccharide; PGN, Peptidoglycan; Created with BioRender.com.